Liver-specific expression of interferon γ following adenoviral gene transfer controls hepatitis B virus replication in mice

Gene Therapy

Volumn 12, Issue 8, 2005, Pages 668-677

  Dumortier, J ^a   Schonig K ^a,b   Oberwinkler, H ^a,c   Low R ^a   Giese, T ^a   Bujard, H ^a   Schirmacher, P ^c   Protzer, U ^a,c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Adenovirus vector; Cytokine; Doxycyclin; HBV; Liver; Luciferase; Tet system

Indexed keywords

ADENOVIRUS VECTOR; ALPHA INTERFERON; BETA INTERFERON; CYTOKINE; DOXYCYCLINE; GAMMA INTERFERON; GREEN FLUORESCENT PROTEIN; LUCIFERASE; TETRACYCLINE;

ADENOVIRUS 5; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; GENE EXPRESSION REGULATION; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HUMAN; HUMAN CELL; INTERFERON INDUCTION; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TISSUE SPECIFICITY; TRANSACTIVATION; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRUS INHIBITION; VIRUS REPLICATION;

ADENOVIRIDAE; ANIMALS; ANTIVIRAL AGENTS; CELL LINE; DOXYCYCLINE; GENE EXPRESSION; GENE THERAPY; GENETIC ENGINEERING; GENETIC VECTORS; HEPATITIS B; HEPATITIS B VIRUS; INTERFERON TYPE II; LIVER; LUCIFERASES; MICE; MICE, TRANSGENIC; PROMOTER REGIONS (GENETICS); VIRUS REPLICATION;

ADENOVIRIDAE; ANIMALIA; HEPATITIS B VIRUS; MUS MUSCULUS;

EID: 17644390201     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3302449     Document Type: Article

References (52)

1. Guidotti LG et al. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 1996; 4: 25-36.
2. Cavanaugh VJ, Guidotti LG, Chisari FV. Interleukin-12 inhibits hepatitis B virus replication in transgenic mice. J Virol 1997; 71: 3236-3243.
3. Kimura K et al. Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice. J Virol 2002; 76: 10702-10707.
4. Frese M et al. Interferon-gamma inhibits replication of sub-genomic and genomic hepatitis C virus RNAs. Hepatology 2002; 35: 694-703.
5. Protzer U et al. Interferon gene transfer by a hepatitis B virus vector efficiently suppresses wild-type virus infection. Proc Natl Acad Sci USA 1999; 96: 10818-10823.
6. Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 1992; 89: 5547-5551.
7. Gossen M et al. Transcriptional activation by tetracyclines in mammalian cells. Science 1995; 268: 1766-1769.
8. Baron U, Freundlieb S, Gossen M, Bujard H. Co-regulation of two gene activities by tetracycline via a bidirectional promoter. Nucleic Acids Res 1995; 23: 3605-3606.
9. Kistner A et al. Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc Natl Acad Sci USA 1996; 93: 10933-10938.
10. Hasan MT et al. Long-term, noninvasive imaging of regulated gene expression in living mice. Genesis 2001; 29: 116-122.
11. Urlinger S et al. Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. Proc Natl Acad Sci USA 2000; 97: 7963-7968.
12. Baron U, Bujard H. Tet repressor-based system for regulated gene expression in eukaryotic cells: principles and advances. Methods Enzymol 2000; 327: 401-421.
13. Gossen M, Bujard H. Studying gene function in eukaryotes by conditional gene inactivation. Annu Rev Genet 2002; 36: 153-173.
14. Molin M et al. Two novel adenovirus vector systems permitting regulated protein expression in gene transfer experiments. J Virol 1998; 72: 8358-8361.
15. Corti O et al. A single adenovirus vector mediates doxycycline-controlled expression of tyrosine hydroxylase in brain grafts of human neural progenitors. Nat Biotechnol 1999; 17: 349-354.
16. Rubinchik S et al. Adenoviral vector which delivers FasL-GFP fusion protein regulated by the tet-inducible expression system. Gene Therapy 2000; 7: 875-885.
17. Aurisicchio L et al. Regulated and prolonged expression of mIFN(alpha) in immunocompetent mice mediated by a helper-dependent adenovirus vector. Gene Therapy 2001; 8: 1817-1825.
18. Haberman RP, McCown TJ, Samulski RJ. Inducible long-term gene expression in brain with adeno-associated virus gene transfer. Gene Therapy 1998; 5: 1604-1611.
19. Fitzsimons HL, McKenzie JM, During MJ. Insulators coupled to a minimal bidirectional tet cassette for tight regulation of rAAV-mediated gene transfer in the mammalian brain. Gene Therapy 2001; 8: 1675-1681.
20. Rendahl KG et al. Tightly regulated long-term erythropoietin expression in vivo using tet-inducible recombinant adeno-associated viral vectors. Hum Gene Ther 2002; 13: 335-342.
21. Paulus W et al. Self-contained, tetracycline-regulated retroviral vector system for gene delivery to mammalian cells. J Virol 1996; 70: 62-67.
22. Hofmann A, Nolan GP, Blau HM. Rapid retroviral delivery of tetracycline-inducible genes in a single autoregulatory cassette. Proc Natl Acad Sci USA 1996; 93: 5185-5190.
23. Reiser J, Lai Z, Zhang XY, Brady RO. Development of multigene and regulated lentivirus vectors. J Virol 2000; 74: 10589-10599.
24. Kafri T, van Praag H, Gage FH, Verma IM. Lentiviral vectors: regulated gene expression. Mol Ther 2000; 1: 516-521.
25. Ho DY, McLaughlin JR, Sapolsky RM. Inducible gene expression from defective herpes simplex virus vectors using the tetracycline-responsive promoter system. Brain Res Mol Brain Res 1996; 41: 200-209.
26. He TC et al. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 1998; 95: 2509-2514.
27. Steinwaerder DS, Lieber A. Insulation from viral transcriptional regulatory elements improves inducible transgene expression from adenovirus vectors in vitro and in vivo. Gene Therapy 2000; 7: 556-567.
28. Rubinchik S et al. Creation of a new transgene cloning site near the right ITR of Ad5 results in reduced enhancer interference with tissue-specific and regulatable promoters. Gene Therapy 2001; 8: 247-253.
29. Talbot D, Descombes P, Schibler U. The 5′ flanking region of the rat LAP (C/EBP beta) gene can direct high-level, position-independent, copy number-dependent expression in multiple tissues in transgenic mice. Nucleic Acids Res 1994; 22: 756-766.
30. Schönig K, Schwenk F, Rajewsky K, Bujard H. Stringent doxycycline dependent control of CRE recombinase in vivo. Nucleic Acids Res 2002; 30: 134.
31. Costa RH, Grayson DR. Site-directed mutagenesis of hepatocyte nuclear factor (HNF) binding sites in the mouse transthyretin (TTR) promoter reveal synergistic interactions with its enhancer region. Nucleic Acids Res 1991; 19: 4139-4145.
32. Schulze-Bergkamen H et al. Primary human hepatocytes - a valuable tool for investigation of apoptosis and hepatitis B virus infection. J Hepatol 2003; 38: 736-744.
33. Gallagher AR et al. Use of the tetracycline system for inducible protein synthesis in the kidney. J Am Soc Nephrol 2003; 14: 2042-2051.
34. Contag CH et al. Visualizing gene expression in living mammals using a bioluminescent reporter. Photochem Photobiol 1997; 66: 523-531.
35. Agha-Mohammadi S, Lotze MT. Regulatable systems: applications in gene therapy and replicating viruses. J Clin Invest 2000; 105: 1177-1183.
36. Clackson T. Regulated gene expression systems. Gene Therapy 2000; 7: 120-125.
37. Ilan Y, Saito H, Thummala NR, Chowdhury NR. Adenovirus-mediated gene therapy of liver diseases. Semin Liver Dis 1999; 19: 49-59.
38. Breyer B et al. Adenoviral vector-mediated gene transfer for human gene therapy. Curr Gene Ther 2001; 1: 149-162.
39. Harding TC et al. Switching transgene expression in the brain using an adenoviral tetracycline-regulatable system. Nat Biotechnol 1998; 16: 553-555.
40. Johansen J et al. Evaluation of Tet-on system to avoid transgene down-regulation in ex vivo gene transfer to the CNS. Gene Therapy 2002; 9: 1291-1301.
41. Lamartina S et al. Stringent control of gene expression in vivo by using novel doxycycline-dependent trans activators. Hum Gene Ther 2002; 13: 199-210.
42. Schönig K, Bujard H. Generating conditional mouse mutants via tetracyclin-controlled gene expression. In: Hofken MH, Dvan Deursen J (eds) Transgenic Mouse - Methods and Protocols. Humana Press Inc.: Totowa, NJ, 2002, pp 69-104.
43. Rang A, Will H. The tetracycline-responsive promoter contains functional interferon-inducible response elements. Nucleic Acids Res 2000; 28: 1120-1125.
44. Mazzolini G et al. Genetic heterogeneity in the toxicity to systemic adenoviral gene transfer of interleukin-12. Gene Therapy 2001; 8: 259-267.
45. Pitzer C et al. In vivo manipulation of interleukin-2 expression by a retroviral tetracycline (tet)-regulated system. Cancer Gene Ther 1999; 6: 139-146.
46. Nakagawa S, Massie B, Hawley RG. Tetracycline-regulatable adenovirus vectors: pharmacologic properties and clinical potential. Eur J Pharm Sci 2001; 13: 53-60.
47. Cavanaugh VJ, Guidotti LG, Chisari FV. Inhibition of hepatitis B virus replication during adenovirus and cytomegalovirus infections in transgenic mice. J Virol 1998; 72: 2630-2637.
48. Klöcker U, Schultz U, Schaller H, Protzer U. Endotoxin stimulates liver macrophages to release mediators that inhibit an early step in hepadnavirus replication. J Virol 2000; 74: 5525-5533.
49. Uprichard SL, Wieland SF, Althage A, Chisari FV. Transcriptional and posttranscriptional control of hepatitis B virus gene expression. Proc Natl Acad Sci USA 2003; 100: 1310-1315.
50. Wieland SF, Guidotti LG, Chisari FV. Intrahepatic induction of alpha/beta interferon eliminates viral RNA-containing capsids in hepatitis B virus transgenic mice. J Virol 2000; 74: 4165-4173.
51. Sprinzl MF, Oberwinkler H, Schaller H, Protzer U. Transfer of hepatitis B virus genome by adenovirus vectors into cultured cells and mice: crossing the species barrier. J Virol 2001; 75: 5108-5118.
52. Deres K et al. Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids. Science 2003; 299: 893-896.